Long-term renal outcomes associated with sodium glucose cotransporter 2 inhibitors in patients with type 2 diabetes mellitus: A systematic review and meta-analysis.

Xiao-Dan ZhangZhen ZhongYanli LiWangen Li

Published in: Diabetes/metabolism research and reviews (2020)

Overall renal safety and beneficial effects are indicated for SGLT2 inhibitors. Further confirmative data from large trials and real-world studies are needed.

Keyphrases

electronic health record
big data
metabolic syndrome
adipose tissue
skeletal muscle
data analysis
artificial intelligence